BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35495246)

  • 1. Designing, docking and molecular dynamics simulation studies of novel cloperastine analogues as anti-allergic agents: homology modeling and active site prediction for the human histamine H1 receptor.
    Daddam JR; Sreenivasulu B; Peddanna K; Umamahesh K
    RSC Adv; 2020 Jan; 10(8):4745-4754. PubMed ID: 35495246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can human allergy drug fexofenadine, an antagonist of histamine (H
    Sader S; Cai J; Muller ACG; Wu C
    J Mol Graph Model; 2017 Aug; 75():106-116. PubMed ID: 28544909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Silico Analysis, Synthesis, and Biological Evaluation of Triazole Derivatives as H1 Receptor Antagonist.
    Badeliya SN; Panchal II; Panigrahi B; Patel CN
    Curr Drug Discov Technol; 2021; 18(4):492-502. PubMed ID: 32316895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular determinants of ligand binding at the human histamine H
    Cordova-Sintjago TC; Fang L; Bruysters M; Leurs R; Booth RG
    J Chem Pharm Res; 2012 Jun; 4(6):2937-2951. PubMed ID: 25013351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Silico Studies on Anti-Stress Compounds of Ethanolic Root Extract of Hemidesmus indicus L.
    Daddam JR; Sreenivasulu B; Umamahesh K; Peddanna K; Rao DM
    Curr Pharm Biotechnol; 2020; 21(6):502-515. PubMed ID: 31823700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docking and MD study of histamine H4R based on the crystal structure of H1R.
    Feng Z; Hou T; Li Y
    J Mol Graph Model; 2013 Feb; 39():1-12. PubMed ID: 23220277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computation-based virtual screening for designing novel antimalarial drugs by targeting falcipain-III: a structure-based drug designing approach.
    Kesharwani RK; Singh DV; Misra K
    J Vector Borne Dis; 2013; 50(2):93-102. PubMed ID: 23995310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plant systemic acquired resistance compound salicylic acid as a potent inhibitor against SCF (SKP1-CUL1-F-box protein) mediated complex in
    Papathoti NK; Saengchan C; Daddam JR; Thongprom N; Tonpho K; Thanh TL; Buensanteai N
    J Biomol Struct Dyn; 2022 Mar; 40(4):1472-1479. PubMed ID: 33047664
    [No Abstract]   [Full Text] [Related]  

  • 9. Structural Analysis of the Histamine H
    Shiroishi M; Kobayashi T
    Handb Exp Pharmacol; 2017; 241():21-30. PubMed ID: 27826702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docking-based Screening of
    Chaudhary A; Yadav BS; Singh S; Maurya PK; Mishra A; Srivastva S; Varadwaj PK; Singh NK; Mani A
    Pharmacogn Mag; 2017 Oct; 13(Suppl 3):S706-S714. PubMed ID: 29142437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2,4-Diaminopyrimidines as dual ligands at the histamine H1 and H4 receptor-H1/H4-receptor selectivity.
    Hammer SG; Gobleder S; Naporra F; Wittmann HJ; Elz S; Heinrich MR; Strasser A
    Bioorg Med Chem Lett; 2016 Jan; 26(2):292-300. PubMed ID: 26718844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of active compounds from Aegle marmelos CORREA with histamine-1 receptor.
    Nugroho AE; Agistia DD; Tegar M; Purnomo H
    Bioinformation; 2013; 9(8):383-7. PubMed ID: 23750086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homology Modeling of the Human P-glycoprotein (ABCB1) and Insights into Ligand Binding through Molecular Docking Studies.
    Mora Lagares L; Minovski N; Caballero Alfonso AY; Benfenati E; Wellens S; Culot M; Gosselet F; Novič M
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational Analysis of Structure-Based Interactions for Novel H₁-Antihistamines.
    Yang Y; Li Y; Pan Y; Wang J; Lin F; Wang C; Zhang S; Yang L
    Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26797608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico binding characteristics between human histamine H1 receptor and antagonists.
    Wang X; Yang Q; Li M; Yin D; You Q
    J Mol Model; 2010 Sep; 16(9):1529-37. PubMed ID: 20179978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based design of hERG-neutral antihypertensive oxazalone and imidazolone derivatives.
    Aksoydan B; Kantarcioglu I; Erol I; Salmas RE; Durdagi S
    J Mol Graph Model; 2018 Jan; 79():103-117. PubMed ID: 29156380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological profile of astemizole-derived compounds at the histamine H1 and H4 receptor--H1/H4 receptor selectivity.
    Wagner E; Wittmann HJ; Elz S; Strasser A
    Naunyn Schmiedebergs Arch Pharmacol; 2014 Mar; 387(3):235-50. PubMed ID: 24241585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel ligands for the human histamine H1 receptor: synthesis, pharmacology, and comparative molecular field analysis studies of 2-dimethylamino-5-(6)-phenyl-1,2,3,4-tetrahydronaphthalenes.
    Ghoneim OM; Legere JA; Golbraikh A; Tropsha A; Booth RG
    Bioorg Med Chem; 2006 Oct; 14(19):6640-58. PubMed ID: 16782354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unraveling the Structure of Meclizine Dihydrochloride with MicroED.
    Lin J; Unge J; Gonen T
    Adv Sci (Weinh); 2024 Feb; 11(6):e2306435. PubMed ID: 38044280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between histamine H1 receptor and its antagonists by using cell membrane chromatography method.
    Ma W; Zhang D; Li J; Che D; Liu R; Zhang J; Zhang Y
    J Pharm Pharmacol; 2015 Nov; 67(11):1567-74. PubMed ID: 26147217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.